NO20082636L - Anvendelse av DHA og ARA for fremstilling av en sammensetning for forebygging eller behandling av fedme - Google Patents

Anvendelse av DHA og ARA for fremstilling av en sammensetning for forebygging eller behandling av fedme

Info

Publication number
NO20082636L
NO20082636L NO20082636A NO20082636A NO20082636L NO 20082636 L NO20082636 L NO 20082636L NO 20082636 A NO20082636 A NO 20082636A NO 20082636 A NO20082636 A NO 20082636A NO 20082636 L NO20082636 L NO 20082636L
Authority
NO
Norway
Prior art keywords
dha
ara
obesity
prevention
treatment
Prior art date
Application number
NO20082636A
Other languages
English (en)
Norwegian (no)
Inventor
Thomas J Brenna
Joshua C Anthony
Steven C Rumsey
Kristin Morris
Original Assignee
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc
Publication of NO20082636L publication Critical patent/NO20082636L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)
NO20082636A 2006-02-28 2008-06-05 Anvendelse av DHA og ARA for fremstilling av en sammensetning for forebygging eller behandling av fedme NO20082636L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77734506P 2006-02-28 2006-02-28
PCT/US2007/004421 WO2007100561A2 (fr) 2006-02-28 2007-02-19 Utilisation de dha et d'ara pour la preparation d'une composition destinee a la prevention ou au traitement de l'obesite

Publications (1)

Publication Number Publication Date
NO20082636L true NO20082636L (no) 2008-09-29

Family

ID=38220602

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082636A NO20082636L (no) 2006-02-28 2008-06-05 Anvendelse av DHA og ARA for fremstilling av en sammensetning for forebygging eller behandling av fedme

Country Status (12)

Country Link
US (1) US20070203237A1 (fr)
EP (1) EP1988888A2 (fr)
KR (1) KR20080103972A (fr)
CN (1) CN101389322A (fr)
BR (1) BRPI0708378A2 (fr)
CA (1) CA2642969A1 (fr)
IN (1) IN2008DE06532A (fr)
MX (1) MX2008010888A (fr)
NO (1) NO20082636L (fr)
RU (1) RU2456985C2 (fr)
TW (1) TWI388319B (fr)
WO (1) WO2007100561A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007100562A2 (fr) * 2006-02-28 2007-09-07 Bristol-Myers Squibb Company Utilisation de dha et d'ara dans la préparation d'une composition permettant de réduire les niveaux de triglycérides
US20070203235A1 (en) * 2006-02-28 2007-08-30 Rosales Francisco J Method for preventing or treating anemia
AU2007307964B2 (en) * 2006-10-03 2013-06-13 Michael D. Myers Meal replacement compositions and weight control method
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
BRPI1014923A2 (pt) * 2009-04-01 2015-09-01 Nestec Sa Redução do risco de obesidade
WO2010134800A1 (fr) * 2009-05-19 2010-11-25 N.V. Nutricia Agent d'enrichissement du lait destiné à la consommation humaine à forte teneur en protéines et en acides gras polyinsaturés à longue chaîne, destiné à améliorer la répartition du tissu adipeux dans l'organisme
US8452267B2 (en) 2009-11-27 2013-05-28 Eazybreak Oy System and method for granting access to a system
ES2555032T3 (es) 2010-01-19 2015-12-28 Mjn U.S. Holdings Llc Compensación nutricional para dieta de tipo occidental
CN101878819B (zh) * 2010-07-20 2012-02-01 澳优乳业（中国）有限公司 一种含脂联素的婴幼儿配方奶粉及其制备方法
US10251928B2 (en) 2014-11-06 2019-04-09 Mead Johnson Nutrition Company Nutritional supplements containing a peptide component and uses thereof
US11109607B2 (en) 2013-11-18 2021-09-07 Gary Hall Oil-based compositions for enhancing oral health and general wellness in humans
EP3082465A2 (fr) * 2013-12-19 2016-10-26 Abbott Laboratories Composition nutritionnelle comprenant une protéine hydrolysée

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
US20030064950A1 (en) * 2001-02-23 2003-04-03 Ntambi James M. Methods for reducing body fat and increasing lean body mass by reducing stearoyl-CoA desaturase 1 activity
TW200412942A (en) * 2002-08-06 2004-08-01 Abbott Lab Appetite control method
US6753350B1 (en) * 2003-03-24 2004-06-22 Bristol-Myers Squibb Company Method to reduce the incidence of intraventricular hemorrhage in preterm infants
WO2005063050A1 (fr) * 2003-12-19 2005-07-14 Abbott Laboratories Procede pour augmenter la masse maigre et reduire masse adipeuse du nourrisson
SE0303513D0 (sv) * 2003-12-19 2003-12-19 Pronova Biocare As Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof

Also Published As

Publication number Publication date
IN2008DE06532A (fr) 2008-10-24
EP1988888A2 (fr) 2008-11-12
TW200744573A (en) 2007-12-16
WO2007100561A3 (fr) 2007-10-18
CA2642969A1 (fr) 2007-09-07
CN101389322A (zh) 2009-03-18
RU2008134874A (ru) 2010-04-10
TWI388319B (zh) 2013-03-11
US20070203237A1 (en) 2007-08-30
MX2008010888A (es) 2008-09-03
RU2456985C2 (ru) 2012-07-27
BRPI0708378A2 (pt) 2011-06-07
WO2007100561A2 (fr) 2007-09-07
KR20080103972A (ko) 2008-11-28

Similar Documents

Publication Publication Date Title
NO20082636L (no) Anvendelse av DHA og ARA for fremstilling av en sammensetning for forebygging eller behandling av fedme
PL1986669T3 (pl) Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia
WO2011069141A3 (fr) Traitement à l'interféron en combinaison avec un blocage de l'activation de stat3
WO2008054695A3 (fr) Composition et procédé pour le traitement étiologique et la prévention de maladies et/ou de complications associées à la déstabilisation chronique du métabolisme du glucose
UA88464C2 (ru) Способ дермального введения метадоновой композиции с обеспечением системного действия
WO2009079451A3 (fr) Compositions et procédés pour favoriser la guérison d'une plaie
WO2009114810A3 (fr) Utilisation d'ellagitannines comme inhibiteurs de la détection du quorum bactérien
BRPI0722054A2 (pt) Composição, kit, e métodos para diminuir um efeito colateral de tratamento com um inibidor da calcineurina, para aumentar um efeito terapêutico de um inibidor da calcineurina e para mudar a concentração de tacrolimus ou um análogo de tacrolimus em um compartimento fisiológico.
WO2007103719A3 (fr) MODULATEURS DE LA 11-β-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE DE TYPE 1, LEURS COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCÉDÉS D'UTILISATION
AU2008267058A8 (en) Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
MX2010005676A (es) Metodo para retrasar el comienzo de esclerosis multiple clinicamente definida.
ME02450B (fr) Traitements antitumoraux perfectionnés
NZ599605A (en) Hemostatic compositions and therapeutic regimens
WO2009154840A3 (fr) Compositions et méthodes utilisant des cellules souches dans la cicatrisation de plaies cutanées
WO2008070859A3 (fr) Traitement d'affections cutanées par dickkopf1 (dkk1)
WO2009048778A3 (fr) Laminines, dérivés, compositions les contenant, et procédé pour leur utilisation thérapeutique
WO2008112773A3 (fr) Droxidopa et composition pharmaceutique de celle-ci pour le traitement de l'hypotension véhiculée par voie neurale
DK2043637T3 (da) Fremgangsmåder og medikamenter til administrering af ibuprofen
WO2007012022A3 (fr) Forme posologique unitaire renfermant un melange d'ibuprofene et de famotidine
ATE457729T1 (de) Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie
WO2008012796A3 (fr) Compositions pharmaceutiques comprenant ccl2 et leur utilisation dans le traitement d'une inflammation
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
WO2008063563A3 (fr) Méthodes de traitement de maladies liées à l'hyperprolifération de la kératine au moyen d'inhibiteurs de mtor
NO20075199L (no) Treatment or prevention of pruritus
BR112012028153A2 (pt) composição farmacêutica e método para o tratamento de hipertensão

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application